L.M. Kohn & Company Abb Vie Inc. Transaction History
L.M. Kohn & Company
- $390 Million
- Q3 2024
A detailed history of L.M. Kohn & Company transactions in Abb Vie Inc. stock. As of the latest transaction made, L.M. Kohn & Company holds 13,075 shares of ABBV stock, worth $2.23 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
13,075
Previous 13,309
1.76%
Holding current value
$2.23 Million
Previous $2.28 Million
13.15%
% of portfolio
0.66%
Previous 0.63%
Shares
11 transactions
Others Institutions Holding ABBV
# of Institutions
3,869Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$29.3 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.5 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$8.93 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.61 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $302B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...